Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study
NCT02308644
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Macular Edema
Interventions
DRUG:
intravitreal bevacizumab injection(1.25mg)
Sponsor
University of Sao Paulo